Literature DB >> 17512639

Microarray analyses of pituitary adenylate cyclase activating polypeptide (PACAP)-regulated gene targets in sympathetic neurons.

Karen M Braas1, Kristin C Schutz, Jeffrey P Bond, Margaret A Vizzard, Beatrice M Girard, Victor May.   

Abstract

The high and preferential expression of the PAC(1)(short)HOP1 receptor in postganglionic sympathetic neurons facilitates microarray studies for mechanisms underlying PACAP-mediate neurotrophic signaling in a physiological context. Replicate primary sympathetic neuronal cultures were treated with 100 nM PACAP27 either acutely (9 h) or chronically (96 h) before RNA extraction and preparation for Affymetrix microarray analysis. Compared to untreated control cultures, acute PACAP treatment modulated significantly the expression of 147 transcripts of diverse functional groups, including peptides, growth factors/cytokines, transcriptional factors, receptors/signaling effectors and cell cycle regulators, that collectively appeared to facilitate neuronal plasticity, differentiation and/or regeneration processes. Some regulated transcripts, for example, were related to BDNF/TrkB, IL-6/Jak2/Socs2 and TGF/follistatin signaling; many transcripts affected bioactive peptide and polyamine biosynthesis. Although chronic PACAP treatments altered the expression of 109 sympathetic transcripts, only 43 transcripts were shared between the acute and chronic treatment data sets. The PACAP-mediated changes in transcript expression were corroborated independently by quantitative PCR measurement. The PACAP-regulated transcripts in sympathetic neurons did not bear strong resemblance to those in PACAP-treated pheochromocytoma cells. However, many PACAP-targeted sympathetic transcripts, especially those related to peptide plasticity and nerve regeneration processes, coincided significantly with genes altered after peripheral nerve injury. The ability for sympathetic PAC(1)(short)HOP1 receptors to engage multiple downstream signaling cascades appeared to be reflected in the number and diversity of genes targeted in a multifaceted strategy for comprehensive neurotrophic responses.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17512639      PMCID: PMC2744890          DOI: 10.1016/j.peptides.2007.04.004

Source DB:  PubMed          Journal:  Peptides        ISSN: 0196-9781            Impact factor:   3.750


  69 in total

1.  Significance analysis of time course microarray experiments.

Authors:  John D Storey; Wenzhong Xiao; Jeffrey T Leek; Ronald G Tompkins; Ronald W Davis
Journal:  Proc Natl Acad Sci U S A       Date:  2005-09-02       Impact factor: 11.205

2.  Pituitary adenylate cyclase-activating polypeptide (PACAP-38) protects cerebellar granule neurons from apoptosis by activating the mitogen-activated protein kinase (MAP kinase) pathway.

Authors:  M Villalba; J Bockaert; L Journot
Journal:  J Neurosci       Date:  1997-01-01       Impact factor: 6.167

3.  PACAP immunoreactivity in the rat superior cervical ganglion in comparison to VIP.

Authors:  L Klimaschewski; C Hauser; C Heym
Journal:  Neuroreport       Date:  1996-11-04       Impact factor: 1.837

4.  Alternative splicing in the N-terminal extracellular domain of the pituitary adenylate cyclase-activating polypeptide (PACAP) receptor modulates receptor selectivity and relative potencies of PACAP-27 and PACAP-38 in phospholipase C activation.

Authors:  C Pantaloni; P Brabet; B Bilanges; A Dumuis; S Houssami; D Spengler; J Bockaert; L Journot
Journal:  J Biol Chem       Date:  1996-09-06       Impact factor: 5.157

5.  Pituitary adenylate cyclase-activating polypeptides directly stimulate sympathetic neuron neuropeptide Y release through PAC(1) receptor isoform activation of specific intracellular signaling pathways.

Authors:  K M Braas; V May
Journal:  J Biol Chem       Date:  1999-09-24       Impact factor: 5.157

6.  Amphiregulin acts as an autocrine survival factor for adult sensory neurons.

Authors:  Anna Nilsson; Martin Kanje
Journal:  Neuroreport       Date:  2005-02-28       Impact factor: 1.837

7.  Pituitary adenylate cyclase activating polypeptide and PAC1 receptor signaling increase Homer 1a expression in central and peripheral neurons.

Authors:  Beatrice M Girard; Emily T Keller; Kristin C Schutz; Victor May; Karen M Braas
Journal:  Regul Pept       Date:  2004-12-15

8.  Transcriptome of pituitary adenylate cyclase-activating polypeptide-differentiated PC12 cells.

Authors:  Masami Ishido; Yoshinori Masuo
Journal:  Regul Pept       Date:  2004-12-15

9.  Accelerated recovery following polyamines and aminoguanidine treatment after facial nerve injury in rats.

Authors:  V H Gilad; W G Tetzlaff; J M Rabey; G M Gilad
Journal:  Brain Res       Date:  1996-06-10       Impact factor: 3.252

10.  Expression of pituitary adenylate cyclase-activating polypeptide in dorsal root ganglia following axotomy: time course and coexistence.

Authors:  Q Zhang; T J Shi; R R Ji; Y Z Zhang; F Sundler; J Hannibal; J Fahrenkrug; T Hökfelt; Y Zhang
Journal:  Brain Res       Date:  1995-12-24       Impact factor: 3.252

View more
  20 in total

1.  Stimulation of synthesis and release of brain-derived neurotropic factor from intestinal smooth muscle cells by substance P and pituitary adenylate cyclase-activating peptide.

Authors:  M Al-Qudah; R Alkahtani; H I Akbarali; K S Murthy; J R Grider
Journal:  Neurogastroenterol Motil       Date:  2015-06-18       Impact factor: 3.598

Review 2.  Pituitary adenylate cyclase activating polypeptide in stress-related disorders: data convergence from animal and human studies.

Authors:  Sayamwong E Hammack; Victor May
Journal:  Biol Psychiatry       Date:  2014-12-09       Impact factor: 13.382

3.  Pituitary adenylate cyclase-activating polypeptide (PACAP) signalling enhances osteogenesis in UMR-106 cell line.

Authors:  Tamás Juhász; Csaba Matta; Éva Katona; Csilla Somogyi; Roland Takács; Tibor Hajdú; Solveig Lind Helgadottir; János Fodor; László Csernoch; Gábor Tóth; Éva Bakó; Dóra Reglődi; Andrea Tamás; Róza Zákány
Journal:  J Mol Neurosci       Date:  2014-08-12       Impact factor: 3.444

4.  The Effects of Prior Stress on Anxiety-Like Responding to Intra-BNST Pituitary Adenylate Cyclase Activating Polypeptide in Male and Female Rats.

Authors:  S Bradley King; Kim R Lezak; Micaela O'Reilly; Donna J Toufexis; William A Falls; Karen Braas; Victor May; Sayamwong E Hammack
Journal:  Neuropsychopharmacology       Date:  2017-01-20       Impact factor: 7.853

5.  PACAP/PAC1R signaling modulates acetylcholine release at neuronal nicotinic synapses.

Authors:  Phyllis C Pugh; Selwyn S Jayakar; Joseph F Margiotta
Journal:  Mol Cell Neurosci       Date:  2009-12-01       Impact factor: 4.314

6.  Chronic stress increases pituitary adenylate cyclase-activating peptide (PACAP) and brain-derived neurotrophic factor (BDNF) mRNA expression in the bed nucleus of the stria terminalis (BNST): roles for PACAP in anxiety-like behavior.

Authors:  Sayamwong E Hammack; Joseph Cheung; Kimberly M Rhodes; Kristin C Schutz; William A Falls; Karen M Braas; Victor May
Journal:  Psychoneuroendocrinology       Date:  2009-01-31       Impact factor: 4.905

7.  Receptors for NPY and PACAP differ in expression and activity during adipogenesis in the murine 3T3-L1 fibroblast cell line.

Authors:  Martin T Gericke; Joanna Kosacka; Daniela Koch; Marcin Nowicki; Thomas Schröder; Albert M Ricken; Karen Nieber; Katharina Spanel-Borowski
Journal:  Br J Pharmacol       Date:  2009-04-27       Impact factor: 8.739

8.  Effects of PACAP on the circadian changes of signaling pathways in chicken pinealocytes.

Authors:  Boglarka Racz; Gabriella Horvath; Nandor Faluhelyi; Andras D Nagy; Andrea Tamas; Peter Kiss; Ferenc Gallyas; Gabor Toth; Balazs Gaszner; Valer Csernus; Dora Reglodi
Journal:  J Mol Neurosci       Date:  2008-07-01       Impact factor: 3.444

9.  Pituitary adenylate cyclase-activating polypeptide (PACAP) alters parasympathetic neuron gene expression in a time-dependent fashion.

Authors:  Adriane D Sumner; Joseph F Margiotta
Journal:  J Mol Neurosci       Date:  2008-07-02       Impact factor: 3.444

Review 10.  Role of PACAP in ischemic neural death.

Authors:  Hirokazu Ohtaki; Tomoya Nakamachi; Kenji Dohi; Seiji Shioda
Journal:  J Mol Neurosci       Date:  2008-05-16       Impact factor: 3.444

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.